Literature DB >> 4305401

Herpes zoster and multiple sclerosis.

J A Lenman, T J Peters.   

Abstract

No significant difference was found between 50 consecutive patients with multiple sclerosis and matched controls in respect of previous infection with rubella or measles and chicken-pox, or of previous vaccination and immunizing injections. Significantly more patients had a past history of herpes zoster compared with the controls.

Entities:  

Mesh：

Year:  1969        PMID： 4305401      PMCID： PMC1983101          DOI： 10.1136/bmj.2.5651.218

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  7 in total

1.  INFECTIVE AGENTS AND MULTIPLE SCLEROSIS.

Authors:  C A ROSS; J A LENMAN; C RUTTER
Journal:  Br Med J       Date:  1965-01-23

2.  Acute demyelinating disease complicating herpes zoster.

Authors:  D McALPINE; Y KUROIWA; Y TOYOKURA; S ARAKI
Journal:  J Neurol Neurosurg Psychiatry       Date:  1959-05       Impact factor: 10.154

3.  Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans, Louisiana. II. A controlled investigation of factors in the life history of the Winnipeg patients.

Authors:  K B WESTLUND; L T KURLAND
Journal:  Am J Hyg       Date:  1953-05

4.  Viruses and the neuroglia with special reference to scrapie, kuru and disseminated sclerosis.

Authors:  H E Webb
Journal:  Proc R Soc Med       Date:  1967-07-07

5.  Multiple sclerosis and vaccination.

Authors:  H Miller; W Cendrowski; K Shapira
Journal:  Br Med J       Date:  1967-04-22

6.  Lymphocyte transformation in mutliple sclerosis induced by cerebrospinal fluid.

Authors:  I Fowler; C E Morris; T Whitley
Journal:  N Engl J Med       Date:  1966-11-10       Impact factor: 91.245

7.  Multiple sclerosis with amyotrophy complicated by oligodendroglioma. History of recurrent herpes zoster.

Authors:  R O Barnard; E H Jellinek
Journal:  J Neurol Sci       Date:  1967 Nov-Dec       Impact factor: 3.181
  7 in total
  8 in total

1.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Ruth Ann Marrie; Christina Wolfson
Journal:  Can J Infect Dis       Date:  2002-03

2.  Epidemiology of multiple sclerosis in the north-east (Grampian region) of Scotland--an update.

Authors:  J G Phadke; A W Downie
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

3.  Varicella-zoster virus at relapses of multiple sclerosis.

Authors:  Julio Sotelo; Graciela Ordoñez; Benjamin Pineda
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

4.  Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management.

Authors:  Ann M Arvin; Jerry S Wolinsky; Ludwig Kappos; Michele I Morris; Anthony T Reder; Carlo Tornatore; Anne Gershon; Michael Gershon; Myron J Levin; Mauritz Bezuidenhoudt; Norman Putzki
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

5.  Antibody response in seropositive multiple sclerosis patients vaccinated with attenuated live varicella zoster virus.

Authors:  R Ross; M Dawood; M Cheang; L E Nicolle
Journal:  Can J Infect Dis       Date:  1996-09

6.  Serum measles antibodies in multiple sclerosis.

Authors:  W Cendrowski; I Polna; K Niedzielska
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-02       Impact factor: 10.154

7.  Varicella zoster virus and relapsing remitting multiple sclerosis.

Authors:  Julio Sotelo; Teresa Corona
Journal:  Mult Scler Int       Date:  2011-03-30

8.  Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.

Authors:  Michael P Pender; Peter A Csurhes; Jacqueline M Burrows; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2017-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.